Congratulations to Edward F. Patz, Jr. MD., who received a Translational Research Partnership Award from the Department of Defense, Lung Cancer Research Program. This work on, A Novel Immune-Modulating Antibody for the Treatment of Lung Cancer, will complement a phase 1 clinical trial that will begin to enroll patients this summer exploring a novel human-derived antibody for the treatment of cancer.